Also, there is potential for clinical trials comparing standard chemotherapy to PD1/PDL1 inhibition in SCCO as our subset of SCCO patients showed increased expression of PD1 and PDL1. This evidence concerns the gene CD274 and ovarian small cell carcinoma.